[1]新华社.习近平对吉林长春长生生物疫苗案件作出重要指示[EB/OL].(2018-07-23)[2018-09-10].http://www.xinhuanet.com/politics/2018-07/23/c_1123166080.htm.
[2]王进发.87例医疗事故鉴定中以药物使用为主因的案例分析[J].中国医院药学杂志,2011,31(6):501-503.
WANG J F.Case analysis of 87 cases of medical accident identification based on drug use[J].Chinese Journal of Hospital Pharmacy,2011,31(6):501-503.
[3]余明永.医疗损害赔偿纠纷[M].北京:法律出版社,2010.
YU M Y.Medical damage compensation disputes[M].Beijing:Law Press,2010.
[4]邓姣娟,穆娇,刘龙清,等.98例医疗过错鉴定的回顾性分析[J].中国法医学杂志,2015,30(4):401-403.DOI:10.13618/j.issn.1001-5728.2015.04.016.
DENG J J,MU J,LIU L Q,et al.Retrospective study on 98 cases of medical treatment faults[J].Chinese Journal of Forensic Medicine,2015,30(4):401-403.DOI:10.13618/j.issn.1001-5728.2015.04.016.
[5]《法律法规案例注释版系列》编写组.医疗事故处理条例[M].北京:中国法制出版社,2015.
[6]最高人民法院《关于审理人身损害赔偿案件适用法律若干问题的解释》[J].人民检察,2004,49(1):75-77.
Interpretation of the Supreme People's Court on several questions on the application of law in the trial of personal damage compensation cases[J].People's Procuratorial Monthly,2004,49(1):75-77.
[7]宁超,王蓉,李淼,等.医疗损害责任纠纷重复鉴定4例[J].中国司法鉴定,2017,8(5):105-108.DOI:10.3969/j.issn.1671-2072.2017.05.021.
NING C,WANG R,LI M,et al.Repeated identification of medical damage liability disputes in 4 cases[J].Chinese Journal of Forensic Sciences,2017,8(5):105-108.DOI:10.3969/j.issn.1671-2072.2017.05.021.
[8]中国裁判文书网.李梅、刘美伦等与中国人民解放军第一〇五医院医疗损害责任纠纷一审民事判决书[EB/OL].(2016-10-28)[2018-09-10].http://wenshu.court.gov.cn/content/content?DocID=4543ffd7-d3e5-4dc5-a971-39b257ac6450&KeyWord.
[9]中国裁判文书网.何某与武汉科技大学附属天佑医院、湖北省妇幼保健院医疗损害责任纠纷二审民事判决书[EB/OL].(2016-02-14)[2018-09-10].http://wenshu.court.gov.cn/content/content?DocID=6645e18b-a038-404d-bbbe-2e6257b7322e&KeyWord=.
[10]中国裁判文书网.张婷辉与秦皇岛市妇幼保健院医疗损害责任纠纷一审民事判决书[EB/OL].(2017-09-08)[2018-09-10].http://wenshu.court.gov.cn/content/content?DocID=ed3cbb64-89ce-4bf4-ac4e-a7e80011ea52&KeyWord=.
[11]中华人民共和国药品管理法[M].北京:中国民主法制出版社,2015.
[12]中华人民共和国执业医师法(中华人民共和国主席令第5号)[EB/OL].(1998-06-26)[2018-09-10].http://www.moh.gov.cn/mohyzs/s3580/200804/18250.shtml.
[13]处方管理办法[M].北京:中国法制出版社,2006.
[14]邓斌,洪晓丹,姚秋燕,等.4例超说明书用药致医疗纠纷的典型案例分析[J].中国医院药学杂志,2018,38(1):88-91.
DENG B,HONG X D,YAO Q Y,et al.Case analysis of 4 typical medical disputes caused by off-label use of drugs[J].Chinese Journal of Hospital Pharmacy,2018,38(1):88-91.
[15]中国裁判文书网.程金珍与乐平市人民医院医疗损害责任纠纷一审民事判决书[EB/OL].(2018-02-05)[2018-09-10].http://wenshu.court.gov.cn/content/content?DocID=3dbf009a-65d2-4433-895c-a87c00349c19&KeyWord=.
[16]邢玥,董梅.我院163例肿瘤患者营养支持类药品致不良反应的关联性研究[J].中国药房,2018,29(15):2122-2125.DOI:10.6039/j.issn.1001-0408.2018.15.24.
XING Y,DONG M.Correlation study on adverse drug reaction induced by nutrition support drugs of 163 cases of tumor patients in our hospital[J].China Pharmacy,2018,29(15):2122-2125.DOI:10.6039/j.issn.1001-0408.2018.15.24.
[17]玉顺子.药物不良事件引起的医疗纠纷案例分析[J].中国医院药学杂志,2014,34(17):1523-1526.
YU S Z.Case analysis on the adverse drug reaction events induced medical disputes[J].Chinese Journal of Hospital Pharmacy,2014,34(17):1523-1526.
[18]国家卫生计生委关于印发抗菌药物临床应用指导原则(2015年版)的通知[EB/OL].(2017-08-19)[2018-09-10].http://www.hnpa.org.cn/articles/2277/2017-8/36031.html.
[19]麻醉药品和精神药品管理条例[EB/OL].(2008-03-28)[2018-09-10].http://www.gov.cn/zhengce/content/2008-03/28/content_6269.htm.
[20]宁超.医疗损害赔偿纠纷判例研究——以中国裁判文书网2005—2015年997个判例为对象[D].太原:山西医科大学,2016.
NING C.Study on precedent case about the dissension of medical damage compensation——taking 977 cases of China Judgments Online from 2005 to 2015 as the object of study[D].Taiyuan:Shanxi Medical University,2016.
[21]安林静,刘婉姝,张丽娜,等.移动护理信息系统在临床用药安全实践中的效果评价[J].解放军药学学报,2017,33(4):382-383.
AN L J,LIU W S,ZHANG L N,et al.Effectiveness of mobile care information system in clinical drug safety[J].Pharmaceutical Journal of Chinese People's Liberation Army,2017,33(4):382-383.
[22]沈文超,丁艳.我院促进临床合理用药的信息化实践[J].中国药房,2015,26(10):1426-1428.
SHEN W C,DING Y.Information practice of the promoting of rational drug use in our hospital[J].China Pharmacy,2015,26(10):1426-1428.
[23]聂丽丽,陈妍妍,廖家智,等.基于临床药学知识库的全过程临床用药管理系统构建[J].中国医院管理,2016,36(1):66-67.
NIE L L,CHEN Y Y,LIAO J Z,et al.Construction and evaluation of clinical pharmacy management system based on the clinical knowledge base[J].Chinese Hospital Management,2016,36(1):66-67.
[24]杜欣,张诚,孙爱华,等.血液科病区实施药品安全管理的方法与效果[J].中国药房,2015,26(14):1885-1887.
DU X,ZHANG C,SUN A H,et al.Methods and effects of the implementation of drug safety management in the ward of hematology department[J].China Pharmacy,2015,26(14):1885-1887.
[25]孙喜琢,李野,杨秀梅,等.规范合理用药管理保障医患用药安全[J].药学服务与研究,2011,11(1):1-5.DOI:10.5428/pcar20110101.
SUN X Z,LI Y,YANG X M,et al.Normalizing management of rational use of medicines,guaranteeing safe use of drugs for patients and doctors[J].Pharmaceutical Care and Research,2011,11(1):1-5.DOI:10.5428/pcar20110101.
[26]侯庆源,邱波,张金燕,等.我院加强药品安全管理的实践[J].中国药房,2011,22(37):3477-3479.
HOU Q Y,QIU B,ZHANG J Y,et al.Experience of enhancing the drug safety management in our hospital[J].China Pharmacy,2011,22(37):3477-3479.
[27]魏盈盈,杜光.从医疗纠纷案例看药师在合理用药中的作用[J].中国医院药学杂志,2011,31(17):1457-1459.
WEI Y Y,DU G.The role of pharmacists in rational drug use from medical dispute cases[J].Chinese Journal of Hospital Pharmacy,2011,31(17):1457-1459.